{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "H. R. 4975"}, "official-title": {"#tail": "\n\t", "#text": "To amend the Controlled Substances Act relating to controlled substance analogues."}, "session": {"#tail": "\n\t\t", "#text": "2d Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "I"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20140625", "#text": "June 25, 2014"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "committee-name": [{"#tail": ", and in addition to the Committee on the ", "@committee-id": "HIF00", "#text": "Committee on Energy and Commerce"}, {"#tail": ", for a period to be subsequently determined by the Speaker, in each case for consideration of such\n\t\t\t provisions as fall within the jurisdiction of the committee concerned", "@committee-id": "HJU00", "#text": "Judiciary"}], "sponsor": {"#tail": " (for himself and ", "#text": "Mr. Thornberry", "@name-id": "T000238"}, "cosponsor": {"#tail": ") introduced the following bill; which was referred to the ", "#text": "Mr. Smith of Texas", "@name-id": "S000583"}}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-House", "@bill-type": "olc", "@dms-id": "H82CA2A3A3EEB4460B538B8646CD63EB0", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": [{"short-title": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "act", "#text": "Synthetic Abuse and Labeling of Toxic Substances Act of 2014", "@value": "Synthetic Abuse and Labeling of Toxic Substances Act of 2014", "@proposed": "true"}, "#text": "\n              "}, "#tail": " or the ", "#text": "\n          "}, {"#tail": ".\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "act", "#text": "SALTS Act", "@value": "SALTS Act", "@proposed": "true"}, "#text": "\n            "}], "#text": "This Act may be cited as the \n          ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "#text": "\n      ", "@id": "HBCE75F96A5FB4AA3AC482AA2FE5B8D48"}, {"@section-type": "subsequent-section", "#tail": "\n  ", "text": {"#tail": "\n\t\t\t", "#text": "\n        ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 203 of the Controlled Substances Act", "@value": "Controlled Substances Act/s:203"}, "@entity-type": "law-citation", "#text": "\n          ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n        ", "@entity-type": "uscode", "#text": "21 U.S.C. 813", "@value": "usc/21/813"}, "@parsable-cite": "usc/21/813", "#text": "\n          ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n      ", "#text": "Controlled substance analogues"}, "paragraph": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "quote": [{"#tail": " and inserting ", "#text": "A controlled"}, {"#tail": "; and", "header-in-text": {"#tail": ".\u2014A controlled", "@style": "OLC", "#text": "In general", "@level": "subsection"}, "#text": "\n            (a) "}], "#text": "by striking "}, "enum": {"#tail": "\n        ", "#text": "(1)"}, "@id": "H6326CFC45EEA4982BD7E2558D116AFE6", "#text": "\n        "}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t\t", "#text": "by adding at the end the following:"}, "enum": {"#tail": "\n        ", "#text": "(2)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "subsection": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", the following factors may be considered, along with any\n\t\t\t other relevant factors:", "@entity-type": "act", "#text": "subsection (a)", "@value": "Controlled Substances Act/s:203/ss:a", "@proposed": "true"}, "#text": "In determining whether a controlled substance analogue was intended for human consumption under\n\t\t\t "}, "enum": {"#tail": "\n            ", "#text": "(b)"}, "header": {"#tail": "\n            ", "#text": "Determination"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "The marketing, advertising, and labeling of the substance."}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "@id": "H38E95640BD1845E7A77CD959A5BB5AE3", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "The known efficacy or usefulness of the substance for the marketed, advertised or labeled purpose."}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "@id": "HCFCF86A3CFCB4725B433CC409E4BAAD3", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "The difference between the price at which the substance is sold and the price at which the\n\t\t\t substance it is purported to be or advertised as is normally sold."}, "enum": {"#tail": "\n              ", "#text": "(3)"}, "@id": "H0A916056DE5544F99A1100B7832CFCE5", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "The diversion of the substance from legitimate channels and the clandestine importation,\n\t\t\t manufacture, or distribution of the substance."}, "enum": {"#tail": "\n              ", "#text": "(4)"}, "@id": "HDEE9D617AEA74FC6B5A25A932412763C", "#text": "\n              "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "Whether the defendant knew or should have known the substance was intended to be consumed by\n\t\t\t injection, inhalation, ingestion, or any other immediate means."}, "enum": {"#tail": "\n              ", "#text": "(5)"}, "@id": "HFD7146C5C8C148DABBE0E0B368AFA53B", "#text": "\n              "}], "#text": "\n            ", "@id": "H673882732B484FC6831E70699132B5DD"}, {"#tail": "\n          ", "text": {"#tail": "\n          ", "#text": "For purposes of this section, evidence that a substance was not marketed, advertised, or labeled\n\t\t\t for human consumption, by itself, shall not be sufficient to establish\n\t\t\t that the substance was not intended for human consumption."}, "enum": {"#tail": "\n            ", "#text": "(c)"}, "header": {"#tail": "\n            ", "#text": "Limitation"}, "@display-inline": "no-display-inline", "#text": "\n            ", "@id": "HCFC86BAFFB564B9589B4D1AE654B6F29", "@commented": "no"}], "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "HFA71FCB795E74648B6DB8CA14FCFA62A"}, "#text": "\n        ", "@id": "HD234123DED814BD99953B6E75B771AF5"}], "#text": "\n      ", "@id": "HC245649640464D47A823D84E4A77872A"}], "#text": "\n\t\t", "@id": "HD26C5AC2630945A3A92DC1EBDC20BC5E"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2014-06-25"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 HR 4975 IH: SALTS Act"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. House of Representatives"}, "#text": "\n"}, "#text": "\n"}}}